Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Language
Publication year range
1.
Braz J Med Biol Res ; 29(10): 1379-87, 1996 Oct.
Article in English | MEDLINE | ID: mdl-9181113

ABSTRACT

The antinociceptive effect of purine nucleotides administered systematically (sc) was determined using the formalin and writhing tests in adult male albino mice. The mechanisms underlying nucleotide-induced antinociception were investigated by preinjecting the animals (sc) with specific antagonists for opioid (naloxone, 1 mg/kg), purinergic P1 (caffeine, 5, 10, of 30 mg/kg); theophylline, 10 mg/kg) or purinergic P2 receptors (suramin, 100 mg/kg; Coomassie blue, 30-300 mg/kg; quinidine, 10 mg/kg). Adenosine, adenosine monophosphate (AMP), diphosphate (ADP) and triphosphate (ATP) caused a reduction in the number of writhes and in the time of licking the formalin-injected paw. Naloxone had no effect on adenosine- or adenine nucleotide-induced antinociception. Caffeine (30 mg/kg) and theophylline (10 mg/kg) reversed the antinociceptive action of adenosine and adenine nucleotide derivatives in both tests. P2 antagonists did not reverse adenine nucleotide-induced antinociception. These results suggest that antinociceptive effect of adenine nucleotides is mediated by adenosine.


Subject(s)
Nociceptors/drug effects , Purine Nucleotides/pharmacology , Analgesics/pharmacology , Animals , Caffeine/pharmacology , Male , Mice , Naloxone/pharmacology , Narcotic Antagonists/pharmacology , Quinidine/pharmacology , Receptors, Purinergic P1/drug effects , Receptors, Purinergic P2/drug effects , Rosaniline Dyes/pharmacology , Suramin/pharmacology , Theophylline/pharmacology
2.
Braz. j. med. biol. res ; 29(10): 1379-87, Oct. 1996. graf
Article in English | LILACS | ID: lil-186189

ABSTRACT

The antinociceptive effect of purine nucleotides administered systemically (sc) was determined using the formalin and writhing tests in adult male albino mice. The mechanisms underlying nucleotide-induced antinociception were investigated by preinjecting the animals (sc) with specific antagonists for opioid (naloxone, 1 mg/kg), purinergic P1 (caffeine, 5, 10 or 30 mg/kg); theophylline, 10 mg/kg) or purinergic P2 receptors (suramin, 100 mg/kg; Coomassie blue, 30-300 mg/kg; quinidine, 10 mg/kg). Adenosine, adenosine monophosphate (AMP), diphosphate (ADP) and triphosphate (ATP) caused a reduction in the number of writhes and in the time of licking the formalin-injected paw. Naloxone had no effect on adenosine- or adenine nucleotide-induced antinociception. Caffeine (30 mg/kg) and theophylline (10 mg/kg) reversed the antinociceptive action of adenosine and adenine nucleotide derivatives in both tests. P2 antagonists did not reverse adenine nucleotide-induced antinociception. These results suggest that the antinociceptive effect of adenine nucleotides is mediated by adenosine.


Subject(s)
Mice , Animals , Male , Analgesics/pharmacology , Caffeine/pharmacology , Inflammation/drug therapy , Naloxone/pharmacology , Quinidine/pharmacology , Rosaniline Dyes/pharmacology , Suramin/pharmacology , Theophylline/pharmacology , Receptors, Purinergic P1/drug effects , Receptors, Purinergic P2/drug effects
3.
Neurochem Res ; 20(12): 1437-41, 1995 Dec.
Article in English | MEDLINE | ID: mdl-8789605

ABSTRACT

The effect of L-pyroglutamic acid, a metabolite that accumulates in pyroglutamic aciduria, on different neurochemical parameters was investigated in adult male Wistar rats. Glutamate binding, adenylate cyclase activity and G protein coupling to adenylate cyclase were assayed in the presence of the acid. L-pyroglutamic acid decreased Na(+)-dependent and Na(+)-independent glutamate binding. Basal and GMP-PNP stimulated adenylate cyclase activity were not affected by the acid. Furthermore, rats received unilateral intrastriatal injections of 10-300 nmol of buffered L-pyroglutamic acid. Vehicle (0.25 M Tris-Cl, pH 7.35-7.4) was injected into the contralateral striatum. Neurotoxic damage was assessed seven days after the injection by histological examination and by weighing both cerebral hemispheres. No difference in histology or weight could be identified between hemispheres. These results suggest that, although capable of interfering with glutamate binding, pyroglutamate did not cause a major lesion in the present model of neurotoxicity.


Subject(s)
Pyrrolidonecarboxylic Acid/pharmacology , Adenylyl Cyclases/metabolism , Animals , Brain/drug effects , Brain/metabolism , Brain Diseases/chemically induced , Corpus Striatum/drug effects , Corpus Striatum/metabolism , GTP-Binding Proteins/metabolism , Glutamic Acid/metabolism , Guanylyl Imidodiphosphate/pharmacology , Male , Pyrrolidonecarboxylic Acid/metabolism , Pyrrolidonecarboxylic Acid/toxicity , Rats , Rats, Wistar , Sodium/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...